Saravanan Revathy, Raveendaran Vinod
Department of Pharmacology, Sri Venkateshwaraa Medical College, Hospital and Research Centre, Ariyur, Pondicherry, India.
Department of Microbiology, Sri Venkateshwaraa Medical College, Hospital and Research Centre, Ariyur, Pondicherry, India.
J Basic Clin Pharm. 2013 Jun;4(3):56-63. doi: 10.4103/0976-0105.118797.
The number of organisms developing resistance to commonly used antibiotics is increasing among the various generations. The exact national scenario of antimicrobial resistance (AMR) is not known in India owing to the absence of a central monitoring agency.
The aim of this study is to identify the group of organisms developing resistance, to know the classes of drugs against, which resistance has emerged and to assess the possible factors that can favor the development of AMR so that antibiotic policy can be formulated for the proper and effective use of antibiotics.
An observational study was conducted for a period of 1 year from August 2011 to July 2012 in a tertiary care hospital in Pondicherry.
Data regarding culture and sensitivity of the organisms isolated from different sources such as urine, blood, wound swab/pus, stool, sputum and tracheal aspirations were collected from the records of the Microbiology Department. Sample processing, identification of organisms to the genus and/or species level and antimicrobial sensitivity were carried out as per the Clinical and Laboratory Standards Institute guidelines on the 999 samples received.
Out of 999 samples, 125 (12.5%) showed significant growth of organisms exhibiting resistance to either single or multiple drugs. Out of 84 (67.2%) in-patients and 41 (32.8%) out-patient samples, Escherichia was the most common organism isolated with a total of 41 (32.8%), followed by Methicillin sensitive Staphylococcus aureus, 26 (20.8%), Klebsiella 25 (20%), Methicillin resistant Staphylococcus aureus 17 (13.6%), Pseudomonas 10 (8%), Proteus 2 (1.6%), 1 (0.8%) each of Citrobacter and Enterococci. Maximum resistance was observed with commonly used first line antimicrobials such as co-trimoxazole, ampicillin, amoxicillin, amoxyclav, fluoroquinolones, third generation cephalosporins and nalidixic acid. Least resistant or highly sensitive were amikacin, nitrofurantoin, gentamycin and doxycycline among the gram-negative bacteria. Macrolides, clindamycin, gentamycin, nitrofurantoin, vancomycin were the most sensitive antimicrobials against the gram-positive bacteria. Lack of knowledge on the consequences of inappropriate use of antibiotics was exhibited by 63% of subjects in our study.
AMR was more with hospital acquired organisms and against commonly used antibiotics that are available since long period. Variation of resistance and sensitivity pattern with time and geographical location is identified. Periodic AMR monitoring and rotation of antibiotics are suggested to restrict further emergence of resistance.
在不同代际中,对常用抗生素产生耐药性的微生物数量正在增加。由于缺乏中央监测机构,印度抗菌药物耐药性(AMR)的确切国情尚不清楚。
本研究的目的是确定产生耐药性的微生物群体,了解出现耐药性的药物类别,并评估可能有利于AMR发展的因素,以便制定抗生素政策,促进抗生素的合理有效使用。
2011年8月至2012年7月,在本地治里的一家三级护理医院进行了为期1年的观察性研究。
从微生物科记录中收集从尿液、血液、伤口拭子/脓液、粪便、痰液和气管吸出物等不同来源分离出的微生物的培养和药敏数据。根据临床和实验室标准协会指南,对收到的999份样本进行样本处理、微生物属和/或种水平鉴定以及抗菌药敏试验。
在999份样本中,125份(12.5%)显示出对单一或多种药物耐药的微生物显著生长。在84份(67.2%)住院患者样本和41份(32.8%)门诊患者样本中,大肠埃希菌是最常见的分离微生物,共41份(32.8%),其次是甲氧西林敏感金黄色葡萄球菌,26份(20.8%),克雷伯菌25份(20%),甲氧西林耐药金黄色葡萄球菌17份(13.6%),铜绿假单胞菌10份(8%),变形杆菌2份(1.6%),柠檬酸杆菌和肠球菌各1份(0.8%)。在常用的一线抗菌药物中,如复方新诺明、氨苄西林、阿莫西林、阿莫西林克拉维酸、氟喹诺酮类、第三代头孢菌素和萘啶酸,观察到的耐药性最高。在革兰氏阴性菌中,阿米卡星、呋喃妥因、庆大霉素和多西环素的耐药性最低或高度敏感。大环内酯类、克林霉素、庆大霉素、呋喃妥因、万古霉素是对革兰氏阳性菌最敏感的抗菌药物。在我们的研究中,63%的受试者表现出对抗生素使用不当后果缺乏了解。
医院获得性微生物以及长期以来可用的常用抗生素的AMR更高。确定了耐药性和敏感性模式随时间和地理位置的变化。建议定期进行AMR监测和轮换使用抗生素,以限制耐药性的进一步出现。